NuCana Plc (NCNA)
1.025
-0.02
(-2.38%)
USD |
NASDAQ |
Oct 15, 11:53
NuCana Total Long Term Debt (Quarterly) : 0.892M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.892M |
| March 31, 2026 | 0.8967M |
| December 31, 2025 | 0.9093M |
| September 30, 2025 | 0.1831M |
| June 30, 2025 | 0.2111M |
| March 31, 2025 | 0.2233M |
| December 31, 2024 | 0.2379M |
| September 30, 2024 | 0.2964M |
| June 30, 2024 | 0.3552M |
| March 31, 2024 | 0.4283M |
| December 31, 2023 | 0.5048M |
| September 30, 2023 | 0.5517M |
| June 30, 2023 | 0.7183M |
| March 31, 2023 | 0.7443M |
| December 31, 2022 | 0.7686M |
| September 30, 2022 | 0.7613M |
| June 30, 2022 | 0.2866M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.3949M |
| December 31, 2021 | 0.5025M |
| September 30, 2021 | 0.5905M |
| June 30, 2021 | 0.699M |
| March 31, 2021 | 0.7947M |
| December 31, 2020 | 0.8817M |
| September 30, 2020 | 0.9295M |
| June 30, 2020 | 0.8341M |
| March 31, 2020 | 0.9213M |
| December 31, 2019 | 1.068M |
| September 30, 2019 | 0.5385M |
| June 30, 2019 | 0.6109M |
| March 31, 2019 | 0.6893M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 0.00 |
| Mereo BioPharma Group Plc | 0.00 |
| BioNTech SE | 349.05M |
| Silence Therapeutics Plc | 0.009M |
| Compass Pathways Plc | 52.74M |